Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-17

Clinical Trial Update: Zinc Supplementation on Cellular Immunity in Thalassemia Major [Phase 4]

View source ↗

Summary

Phase 4 study evaluating zinc supplementation on cellular immunity in thalassemia major has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zinc supplementation (zinc)

Snippet

Sponsor: Fakultas Kedokteran Universitas Indonesia | Conditions: Thalassemia, Splenectomy; Status | Phase 4 | Status: COMPLETED